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This article reports the data for the effects of C1q tumor necrosis
factor α-related protein isoform 5 (CTRP5) on the palmitate-
induced apoptosis in myocytes. The data obtained from in vitro
cultured myocytes shows that the cellular treatment with the
globular domain of CTRP5 (gCTRP5) signiﬁcantly inhibits the
palmitate-induced MTT reduction, caspase-3 activation, and DNA
fragmentation in a time-dependent manner. The data presented in
this article also shows that AraA, an inhibitor of AMPK, almost
completely abolished the protective effect of gCTRP5 on the DNA
fragmentation induced by palmitate in myocytes. Interpretation of
our data and further extensive insights into the protective role of
CTRP5 in palmitate-induced apoptosis in myocytes can be found in
Yang and Lee (2014) [1].
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations TableSubject area Cell biology, biochemistryore speciﬁc sub-
ject areaObesity, apoptosis, metabolism, cytokinevier Inc. This is an open access article under the CC BY license
chemistry, Dongguk University College of Medicine, Gyeongju 780-714,
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acquiredAnalysis of MTT reduction, caspase-3 activation and DNA fragmentationata format Analyzed
xperimental
factorsL6 GLUT4myc myocytes were treated with palmitate, gCTRP5 or AraA.xperimental
featuresL6 GLUT4myc myocytes were incubated with palmitate (0.5 mM) in the presence
or absence of gCTRP5 (5 μg/ml) for 0–18 h. For inhibition of AMPK, 2 mM of AraA
was co-treated during the incubation.ata source
locationDongguk University School of Medicine, Gyeongju 780–714, Koreaata accessibility The data are supplied with this articleValue of the data
 The protective effect of CTRP5, an adipokine paralog, on palmitate-induced cytotoxicity, activation
of caspase-3, and DNA fragmentation is unveiled in myocytes.
 The functional analysis of CTRP5 provides an insight into the regulation of cell survival and
apoptosis by the fatty acids accumulation and C1q complement-related cytokines.
 This data allows to predict biological signiﬁcance of other cytokines containing C1q complement
domain in various diseases associated with obesity and dyslipidemia.1. Data
C1q tumor necrosis factor α-related protein isoform 5 (CTRP5), a member of the CTRP family, has
recently been identiﬁed as a highly conserved family of adiponectin paralog [2]. Adiponectin is an
abundant adipokine involved in the regulation of energy metabolism, such as fatty acid oxidation and
glucose utilization [3]. Similar to adiponectin, we have previously shown that the globular domain of
CTRP5 (gCTRP5) activates AMPK, which subsequently stimulates fatty acid oxidation and glucose
uptake in myocytes [4].
It has been reported that a high concentration of palmitate, the most abundant dietary saturated
fatty acid (SFA), induces apoptosis and insulin resistance in skeletal muscle cells through the acti-
vation of PKC and NFκ-B, increase of oxidative stress and mitochondrial dysfunction, etc. [5–8].
Therefore, we analyzed the protective effect of CTRP5 on SFA-induced lipotoxicity, such as cell via-
bility and apoptosis, in myocytes. We treated L6 GLUT4myc myocytes with 0.5 mM of palmitate for 0–
18 h and the effects of palmitate on cell viability and apoptosis were examined. As shown in Fig. 1, we
found that the cellular treatment with palmitate in L6 GLUT4myc myocytes decreased cell viability, as
assessed by MTT reduction, and increased caspase-3 activity and DNA fragmentation, in a time-
dependent manner. Interestingly, the treatment of gCTRP5 (5 ug/ml) signiﬁcantly rescued the
palmitate-induced cytotoxicity, caspase-3 activation and DNA fragmentation in L6 GLUT4myc myo-
cytes (Fig. 1 A–C).
We next examined whether protective effect of gCTRP5 in palmitate-induced DNA fragmentation
is dependent on AMPK activation in myocytes, because we have previously shown that the anti-
apoptotic effect of gCTRP5 is dependent on AMPK [1]. As we expected, gCTRP5 signiﬁcantly inhibited
the palmitate-induced DNA fragmentation in a dose-dependent manner, whereas gCTRP5 did not
affect DNA fragmentation in the control cells (Fig. 2). Moreover, it is noteworthy that AraA, an inhi-
bitor of AMPK, almost completely abolished the protective effect of gCTRP5 on the DNA fragmentation
induced by palmitate in myocytes (Fig. 2), indicating that the anti-apoptotic effect of gCTRP5 in
palmitate-treated cells is dependent on AMPK activation.
D
N
A 
fr
ag
m
en
ta
tio
n 
(R
el
at
iv
e 
ra
tio
) 
C
as
pa
se
-3
 a
ct
iv
ity
 
(R
el
at
iv
e 
ra
tio
) 
M
TT
 re
du
ct
io
n 
(R
el
at
iv
e 
ra
tio
) 
Fig. 1. gCTRP5 prevents myocytes from palmitate-induced cytotoxicity, caspase-3 activation and DNA fragmentation. L6 GLUT4myc
myocytes were incubated with palmitate (0.5 mM) in the presence (triangle) or absence (circle) of gCTRP5 (5 μg/ml) for 0–18 h.
The values are expressed as the relative ratio, where the level of zero time control was set to one. Values are expressed as
means7SEM of three independent experiments; *, Po0.05; ***, Po0.001.
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2.1. Cell culture and palmitate treatment
L6 GLUT4myc cells, immortalized rat skeletal muscle cells stably expressing GLUT4 containing an
exofacial myc epitope [9], were generously provided by Dr. Amira Klip (the Hospital for Sick Children,
Toronto, Ontario, Canada). The cells differentiate normally from myoblasts to myotubes, when they
were harvested in MEM alpha supplemented with 10% FBS and 1% penicillin–streptomycin [10]. For
the palmitate treatment, the cells were incubated for 6–18 h with BSA or BSA conjugated-palmitate
(0.5 mM) in culture media. If necessary, recombinant gCTRP5 (5 μg/ml) and/or adenine 9-D-arabi-
nofuranoside (AraA, 2 mM), an AMPK inhibitor, were treated with or without palmitate (0.5 mM).
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Fig. 2. Inhibition of AMPK abolished the effect of gCTRP5 against palmitate-induced DNA fragmentation in myocytes. L6 GLUT4myc
myocytes were incubated in the presence or absence of palmitate (0.5 mM for 18 h) and/or globular domain of human CTRP5
(gCTRP5, 5 mg/ml). For inhibition of AMPK, 2 mM of AraA was co-treated during the incubation. DNA fragmentation was
measured by an ELISA assay. The values are expressed as the relative ratio, where the level of the untreated control was set to
one. Values are expressed as means7SEM of three independent experiments; *, Po0.05; ***, Po0.001.
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Palmitate-induced cytotoxicity in L6 GLUT4myc myocytes was measured by MTT (3-[4,5-dime-
thylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay. Brieﬂy, the cells were incubation in media
containing 1.2 mM MTT solution for 4 h. Following incubation, 40% DMSO was added to each well,
and the absorbance was measured at 540 nm. The reduction of MTT was used to determine viability
of cells.2.3. Determination of cell apoptosis
Apoptosis was assessed by measurement of cellular caspase-3 activity, which is based on the
hydrolysis of the peptide substrate of caspase-3, using colorimetric methods according to the man-
ufacturer's instructions (R&D Systems).2.4. Analysis of DNA fragmentation
DNA fragments were quantiﬁed by the Cell Death Detection ELISA Plus (Roche Molecular Bio-
chemicals, Indianapolis, Indiana, USA). In brief, myocytes were rinsed with PBS three times in order to
remove nucleosomes leaked out from necrotic cells and then incubated with the lysis buffer for
30 min. The supernatant containing mono- and oligo-nucleosomes from the cytoplasmic fraction of
apoptotic cells was used for further analyses.2.5. Statistical analysis
Values are expressed as the mean7SEM from at least four independent experiments. Where
applicable, the signiﬁcance of the differences was determined using a Student's t test for the
unpaired data.Acknowledgments
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